A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
Public ClinicalTrials.gov record NCT05318937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinson's Disease Cognitive Impairment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Parkinson's disease mild cognitive impairment (PD-MCI).
Study identification
- NCT ID
- NCT05318937
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 5, 2022
- Primary completion
- Jan 16, 2024
- Completion
- Feb 22, 2024
- Last update posted
- Sep 11, 2025
2022 – 2024
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sage Investigational Site | Sun City | Arizona | 85351 | — |
| Sage Investigational Site | Little Rock | Arkansas | 72205 | — |
| Sage Investigational Site | Fresno | California | 93710 | — |
| Sage Investigational Site | Long Beach | California | 90806 | — |
| Sage Investigational Site | Los Angeles | California | 90048 | — |
| Sage Investigational Site | Reseda | California | 91335 | — |
| Sage Investigational Site | Sacramento | California | 95816 | — |
| Sage Investigational Site | Englewood | Colorado | 80113 | — |
| Sage Investigational Site | Vernon | Connecticut | 06066 | — |
| Sage Investigational Site | Boca Raton | Florida | 33431 | — |
| Sage Investigational Site | Boca Raton | Florida | 33486 | — |
| Sage Investigational Site | Hialeah | Florida | 33012 | — |
| Sage Investigational Site | Miami | Florida | 33032 | — |
| Sage Investigational Site | Orlando | Florida | 32789 | — |
| Sage Investigational Site | Port Orange | Florida | 32127 | — |
| Sage Investigational Site | Tampa | Florida | 33609 | — |
| Sage Investigational Site | Tampa | Florida | 33613 | — |
| Sage Investigational Site | Decatur | Georgia | 30030 | — |
| Sage Investigational Site | Chicago | Illinois | 60611 | — |
| Sage Investigational Site | Kansas City | Kansas | 66160 | — |
| Sage Investigational Site | Bloomington | Minnesota | 55425 | — |
| Sage Investigational Site | Las Vegas | Nevada | 89106 | — |
| Sage Investigational Site | Albany | New York | 12208 | — |
| Sage Investigational Site | New York | New York | 10019 | — |
| Sage Investigational Site | Stony Brook | New York | 11794-8121 | — |
| Sage Investigational Site | Williamsville | New York | 14221 | — |
| Sage Investigational Site | Woodmere | New York | 11598 | — |
| Sage Investigational Site | Raleigh | North Carolina | 27607 | — |
| Sage Investigational Site | Cincinnati | Ohio | 45221 | — |
| Sage Investigational Site | Columbus | Ohio | 43221 | — |
| Sage Investigational Site | Toledo | Ohio | 43614 | — |
| Sage Investigational Site | Memphis | Tennessee | 38157 | — |
| Sage Investigational Site | Nashville | Tennessee | 37232 | — |
| Sage Investigational Site | Houston | Texas | 77030 | — |
| Sage Investigational Site | San Antonio | Texas | 78229 | — |
| Sage Investigational Site | Burlington | Vermont | 05401 | — |
| Sage Investigational Site | Virginia Beach | Virginia | 23502 | — |
| Sage Investigational Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05318937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2025 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05318937 live on ClinicalTrials.gov.